HiDoc Technologies GmbH, dba Cara Care, a Berlin, Germany-based digital health company, raised $7m in Series A funding.
The round was led by JJDC and Barcelona-based VC firm Asabys Partners through its fund Sabadell Asabys Health Innovation Investments SCR, SA, with participation from existing investor Atlantic Labs.
The company intends to use the funds to:
- launch of its Cara Care mobile companion app for people suffering from digestive health issues, with a primary focus on the United States,
- conduct additional scientific research to better understand digestive diseases, symptom triggers and flare-up causes, and
- expand existing partnerships and create new ones with other important players in the patient journey, including those in the pharmaceutical, diagnostic laboratories, and food manufacturing industries.
Founded in 2016 by André Sommer and Jesaja Brinkmann, Cara Care offers a new digital dimension to gastrointestinal healthcare, filling a gap in the journey of patients who spend most of their time outside general physician (GP) and gastroenterologist (GI) offices, especially those who suffer from Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), and Gastroesophageal Reflux Disease (GERD).
To date, Cara Care has allowed more than 400,000 people in Germany and the U.S. to manage the symptoms of digestive diseases such as IBS, IBD, GERD, food intolerances, Crohn’s disease or ulcerative colitis.
It is available in German and English.